Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Emerging roles of JMJD3 in cancer.
Clin Transl Oncol. 2022 Jul;24(7):1238-1249. doi: 10.1007/s12094-021-02773-9. Epub 2022 Mar 3.
Clin Transl Oncol. 2022.
PMID: 35239138
Review.
The function of LncRNA-ATB in cancer.
Anbiyaiee A, Ramazii M, Bajestani SS, Meybodi SM, Keivan M, Khoshnam SE, Farzaneh M.
Anbiyaiee A, et al. Among authors: meybodi sm.
Clin Transl Oncol. 2023 Jan;25(1):1-9. doi: 10.1007/s12094-022-02848-1. Epub 2022 May 21.
Clin Transl Oncol. 2023.
PMID: 35597865
Review.
Item in Clipboard
Correction to: Emerging roles of JMJD3 in cancer.
Farzaneh M, Kuchaki Z, Rashid Sheykhahmad F, Meybodi SM, Abbasi Y, Gholami E, Ghaedrahmati F, Anbiyaee O.
Farzaneh M, et al. Among authors: meybodi sm.
Clin Transl Oncol. 2022 Oct;24(10):2044. doi: 10.1007/s12094-022-02871-2.
Clin Transl Oncol. 2022.
PMID: 35789470
No abstract available.
Item in Clipboard
Eplerenone reduces renal ischaemia/reperfusion injury by modulating Klotho, NF-κB and SIRT1/SIRT3/PGC-1α signalling pathways.
Barati A, Rahbar Saadat Y, Meybodi SM, Nouraei S, Moradi K, Kamrani Moghaddam F, Malekinejad Z, Hosseiniyan Khatibi SM, Zununi Vahed S, Bagheri Y.
Barati A, et al. Among authors: meybodi sm.
J Pharm Pharmacol. 2023 Jun 5;75(6):819-827. doi: 10.1093/jpp/rgac054.
J Pharm Pharmacol. 2023.
PMID: 35866843
Item in Clipboard
Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression.
Sahrayi H, Hosseini E, Karimifard S, Khayam N, Meybodi SM, Amiri S, Bourbour M, Farasati Far B, Akbarzadeh I, Bhia M, Hoskins C, Chaiyasut C.
Sahrayi H, et al. Among authors: meybodi sm.
Pharmaceuticals (Basel). 2021 Dec 21;15(1):6. doi: 10.3390/ph15010006.
Pharmaceuticals (Basel). 2021.
PMID: 35056063
Free PMC article.
Item in Clipboard
Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy.
Meybodi SM, Ejlalidiz M, Manshadi MR, Raeisi M, Zarin M, Kalhor Z, Saberiyan M, Hamblin MR.
Meybodi SM, et al.
Crit Rev Oncol Hematol. 2024 May;197:104340. doi: 10.1016/j.critrevonc.2024.104340. Epub 2024 Apr 1.
Crit Rev Oncol Hematol. 2024.
PMID: 38570176
Free article.
Review.
Item in Clipboard
Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events.
Meybodi SM, Farasati Far B, Pourmolaei A, Baradarbarjastehbaf F, Safaei M, Mohammadkhani N, Samadani AA.
Meybodi SM, et al.
Med Oncol. 2023 Jul 15;40(8):243. doi: 10.1007/s12032-023-02114-6.
Med Oncol. 2023.
PMID: 37453930
Review.
Item in Clipboard
CDKN2B-AS (rs2891168), SOD2 (rs4880), and PON1 (rs662) polymorphisms and susceptibility to coronary artery disease and type 2 diabetes mellitus in Iranian patients: A case-control study.
Yari A, Karam ZM, Meybodi SME, Sargazi ML, Saeidi K.
Yari A, et al. Among authors: meybodi sme.
Health Sci Rep. 2023 Nov 22;6(11):e1717. doi: 10.1002/hsr2.1717. eCollection 2023 Nov.
Health Sci Rep. 2023.
PMID: 38028681
Free PMC article.
Item in Clipboard
Cite
Cite